What’s in the package insert for Dexmethylphenidate (Azstarys)

Dexmethylphenidate (Azstarys) is a central nervous system stimulant prescription drug that has gradually received international attention in recent years. It is mainly used for the treatment of attention deficit hyperactivity disorder (ADHD). ADHD is a common neurodevelopmental disorder, often characterized by inattention, poor impulse control, and hyperactivity. These symptoms not only affect children's learning and behavior, but also cause long-term problems in the work and life of adolescents and adults. The launch of Azstarys provides a new option for the treatment of ADHD. Its unique drug design and relatively stable drug release mode give it certain advantages over similar drugs.

In terms of indications,Azstarys is mainly used to treat ADHD patients aged 6 years and above, including children, adolescents and adults. This group of people widely covers the needs from school-age children to working adults. For the clinical symptoms of patients at different stages, Azstarys helps improve learning efficiency and quality of life by improving attention, extending concentration duration, and reducing impulsive behavior. Compared with traditional methylphenidate drugs, its compound ingredients can form a flatter drug concentration curve in the body, reducing unstable reactions caused by concentration fluctuations.

In terms of dosage and administration,The recommended dosage of Azstarys varies based on age. For patients 6 to 12 years old, the usual starting dose is 39.2 mg/7.8 mg taken orally once daily in the morning with or without food. After one week of treatment, the doctor can moderately adjust the dose based on tolerability and efficacy evaluation, up to a maximum of 52.3mg/10.4mg, or to 26.1mg/5.2mg if tolerance is poor. For adolescents and adult patients aged 13 to 17 years old, the starting dose is also 39.2mg/7.8mg, which can be gradually increased to 52.3mg/10.4mg as a maintenance dose based on clinical response. This gradual adjustment helps reduce the occurrence of adverse reactions while ensuring maximum efficacy.

In terms of adverse reactions,Azstarys is similar to other central stimulants. Common side effects include decreased appetite, weight loss, insomnia, nausea, vomiting, and indigestion. Some patients may also experience dizziness, anxiety, irritability, increased heart rate, or increased blood pressure. Most of these reactions are closely related to the mechanism of drug action. Because it may affect the cardiovascular system, doctors often conduct basic health examinations before taking the medication and conduct regular follow-up visits during the medication to ensure safety. For pediatric patients, parents and doctors need to pay special attention to changes in height and weight to avoid long-term treatment affecting normal development.

In terms of pharmacological effects, Azstarys consists of two parts. Serdexmethylphenidate, as a prodrug, is gradually metabolized in the body and continuously releases dexmethylphenidate, thereby maintaining its medicinal effect for a longer period of time. Dexmethylphenidate itself, as a central nervous system stimulant, can affect the neurotransmission of dopamine and norepinephrine, but its exact mechanism is not yet fully understood. Through the combination of two ingredients, Azstarys can not only provide the advantage of rapid onset of action, but also ensure a long-lasting and stable duration of action, reducing the peak and valley difference in efficacy.

In terms of storage conditions,Azstarys needs to be stored at room temperature between 20°C and 25°C, and the original packaging must be kept sealed to prevent moisture or the loss of pharmaceutical ingredients. As a prescription drug, patients must strictly follow the doctor's instructions during use and cannot increase or decrease the dose at will or stop the drug midway to avoid recurrence of symptoms or adverse events.

Reference materials:https://azstarys.com/